Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Eisai Concludes Strategic Manufacturing Alliance with Biogen Idec for Contract Manufacturing at Eisai Inc.’s US Plant
December 17, 2012
- Elmed Eisai, Kobayashi Kako Get Their Allegra Generics Listed
December 14, 2012
- Calls by MRs from Pfizer Japan Left Best Impression at Insurance Pharmacies in October: Nextit Research
December 14, 2012
- ADCETRIS Shows Tolerability in Untreated HL Patients: Takeda
December 14, 2012
- Lyrica, Other Key Products Upbeat in FY2012 Despite NHI Price Revision: Pfizer Japan Pres. Umeda
December 13, 2012
- Zydus to Build New Plant in India for Japan-Bound Generics
December 13, 2012
- Astellas Initiates PIII Study of Oral Renal Anemia Treatment in US, Europe
December 13, 2012
- Importance of Alliances Increasing in Competitive Diabetes Drug Market
December 13, 2012
- About 50% of FLT3-ITD Positive Patients Achieve CRc in PII Study for Quizartinib: Astellas
December 13, 2012
- Kaken Initiates Voluntary Partial Recall of Empynase-P Tablets 18000
December 13, 2012
- UMN Pharma Listed on TSE Mothers, Sets Midterm Plan Target to Be in Black
December 13, 2012
- Domestic Drug Makers Need to Break from Closed Innovation and Promote Open Innovation: Prof. Teranishi of Kyoto Univ. MIC
December 13, 2012
- [Data] Sales of Takeda’s Mainstay Products in 1st Half of FY2012
December 13, 2012
- [Data] Sales of Daiichi Sankyo’s Mainstay Products in 1st Half of FY2012
December 13, 2012
- [Data] Sales of Otsuka HD’s Mainstay Products in 1st Half of FY2012
December 13, 2012
- [Data] Sales of Astellas’s Mainstay Products in 1st Half of FY2012
December 13, 2012
- [Data] Sales of Eisai’s Mainstay Products in 1st Half of FY2012
December 13, 2012
- [Data] Sales of Dainippon Sumitomo’s Mainstay Products in 1st Half of FY2012
December 13, 2012
- [Data] Sales of Mitsubishi Tanabe’s Mainstay Products in 1st Half of FY2012
December 13, 2012
- [Data] Sales of Taisho HD’s Mainstay Products in 1st Half of FY2012
December 13, 2012
ページ
Japan has entered a third straight year of wage hikes averaging 5%, but the pharmaceutical industry is struggling to keep…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…